Author

Simon Kaja

Loyola University Chicago / Experimentica Ltd. - Cited by 2,993 - Ophthalmic drug discovery

Biography

Dr. Simon Kaja is an Accomplished neuroscientist with 16+ year's experience in the academic, biotech/pharma and CRO setting with strong expertise in ophthalmology, neuroscience, neurology and neuroinflammation. He works in the Department of Ophthalmology, School of Medicine, University of Missouri, Kansas City, USA
Title
Cited by
Year
Mitochondrial-targeted antioxidants attenuate TGF-β2 signaling in human trabecular meshwork cells
VR Rao, JD Lautz, S Kaja, EM Foecking, E Lukács, EB StubbsInvestigative Ophthalmology & Visual Science 60 (10), 3613-3624, 2019201
29
2019
Endothelin-1–Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma
I Pulido, S Ollosi, S Aparisi, JH Becker, A Aliena-Valero, M Benet, ...Cancer research 80 (19), 4224-4232, 2020202
11
2020
PARP inhibition in vivo blocks alcohol-induced brain neurodegeneration and neuroinflammatory cytosolic phospholipase A2 elevations
DE Kouzoukas, JA Schreiber, NF Tajuddin, S Kaja, EJ Neafsey, HY Kim, ...Neurochemistry international 129, 104497, 2019201
8
2019
Structure–Function Relationships in the Rodent Streptozotocin-Induced Model for Diabetic Retinopathy: A Systematic Review
I Lelyte, Z Ahmed, S Kaja, G KalesnykasJournal of Ocular Pharmacology and Therapeutics 38 (), 271-286, 2022202
4
2022
CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity
K Losenkova, A Takeda, S Ragauskas, M Cerrada-Gimenez, M Vähätupa, ...Cellular and Molecular Life Sciences 79 (3), 152, 2022202
4
2022
Agonism of the liver X receptor improves dry eye pathology in vitro and in vivo
SD Ogle, S Kaja, WK Jones, AK GhoshInvestigative Ophthalmology & Visual Science 63 (7), 998–A0328-998–A0328, 2022202
1
2022
Topical porphyrin antioxidant protects against ocular surface pathology in a novel rabbit model for particulate matter-induced dry eye disease
AK Ghosh, M Bacellar-Galdino, S Iqbal, NE Pappenhagen, S KajaJournal of Ocular Pharmacology and Therapeutics 38 (4), 294-304, 2022202
1
2022
Preclinical Efficacy of Pro-and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration
A Acevedo-Jake, S Shi, Z Siddiqui, S Sanyal, R Schur, S Kaja, A Yuan, ...Bioengineering 8 (2), 90, 20220
1
2021
Maturation of retinal pigment epithelium cells in vitro enhances the endogenous antioxidant defense system
JJ Hakkarainen, O Vergun, AK Ghosh, S KajaInvestigative Ophthalmology & Visual Science 62 (8), 206-206, 20220
1
2021
Validation of a novel artificial intelligence (AI) machine learning algorithm for quantification of vascular pathology in preclinical models
J Jarutis, S Bijeikis, S Ragauskas, K Mickevicius, G Kalesnykas, ...Investigative Ophthalmology & Visual Science 62 (8), 278-278, 20220
1
2021
LXR Agonist in Topical Ophthalmic Formulation for Treatment of Dry-Eye Disorder
S Kaja, A Ghosh, WK JonesUS Patent App. 6/7,646, 2020202
1
2020
Automated quantification of CNV volume using deep learning AI algorithm
M Vähätupa, S Ragauskas, A Ziniauskaite, A Knuuttila, HK Sihvo, ...Investigative Ophthalmology & Visual Science 6 (7), 494-494, 2020202
1
2020